N of 1 Study: Methylphenidate in a Patient with Borderline Personality Disorder and Attention Deficit Hyperactivity Disorder

Andrulonis P.A. , Glueck B.C. , Stroebel C.F. Organic brain dysfunction and the borderline syndrome. Psychiatr Clin North Am 1980; 4: 47–66.

Hooberman D. , Stern T.A. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report. J Clin Psychiatry 1984; 45: 441–442.

Stangle D. , Pfohle B. , Zimmerman M. A structured interview for the DSM-III personality disorders. A preliminary report. Arch Gen Psychiatry 1985; 42: 591–596.

Hathaway S.R. , McKinley J.C. Minnesota Multiphasic Personality Inventory. Minneapolis MN: University of Minneapolis, 1942.

Millon T. Millon Clinical Mulhaxial Inventory (second edition) Minnesota MN: Interpretive Scoring Systems, 1982.

Guyatt G. , Sackett D. , Adachi J. A clinician's guide for conducting randomized trials in individual patients. Can Med Assoc J 1988; 139: 497–503.

Guyatt G.H. , Heyting A. , Jaeschke R. N of 1 randomized trials for investigating new drugs. Controlled Clinical Trials 1990; 11: 88–100.

Wechsler D. Wechsler Adult Intelligence Scale. New York NY: Manual Psychological Corporation, 1955.

Strub R.L. , Black F.W. The mental status examination in neurology. Philadelphia PA: FA Davis, 1977.

Drewe F.A. Go-no-go learning after frontal lobe lesions in humans. Cortex 1975; 11: 8–16.

Lezak M.D. Neuropsychological assessment (second edition). New York NY: Oxford University Press, 1983.

Linehan M.M. , Armstrong H.E. , Suarez A. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991; 48: 1060–1064.

Soloff P.T. , George A. , Nathan R.S. Progress in pharmacotherapy of borderline disorders. Arch Gen Psychiatry 1986; 43: 691–697.